Zhaofei Guo

532 total citations
20 papers, 422 citations indexed

About

Zhaofei Guo is a scholar working on Immunology, Biomedical Engineering and Molecular Biology. According to data from OpenAlex, Zhaofei Guo has authored 20 papers receiving a total of 422 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Immunology, 7 papers in Biomedical Engineering and 6 papers in Molecular Biology. Recurrent topics in Zhaofei Guo's work include Immunotherapy and Immune Responses (9 papers), Nanoplatforms for cancer theranostics (7 papers) and Cancer Research and Treatments (6 papers). Zhaofei Guo is often cited by papers focused on Immunotherapy and Immune Responses (9 papers), Nanoplatforms for cancer theranostics (7 papers) and Cancer Research and Treatments (6 papers). Zhaofei Guo collaborates with scholars based in China, Czechia and Germany. Zhaofei Guo's co-authors include Wenfei Chen, Xun Sun, Yining Zhu, Zhirong Zhang, Chun‐Ting He, Nan Qiao, Shuting Bai, Guangsheng Du, Xun Sun and Hairui Wang and has published in prestigious journals such as Advanced Materials, ACS Nano and Biomaterials.

In The Last Decade

Zhaofei Guo

18 papers receiving 418 citations

Peers

Zhaofei Guo
Yingyue Ding United States
Frank A. Veliz United States
Piper A. Rawding United States
Zhaofei Guo
Citations per year, relative to Zhaofei Guo Zhaofei Guo (= 1×) peers Nanhui Liu

Countries citing papers authored by Zhaofei Guo

Since Specialization
Citations

This map shows the geographic impact of Zhaofei Guo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhaofei Guo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhaofei Guo more than expected).

Fields of papers citing papers by Zhaofei Guo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhaofei Guo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhaofei Guo. The network helps show where Zhaofei Guo may publish in the future.

Co-authorship network of co-authors of Zhaofei Guo

This figure shows the co-authorship network connecting the top 25 collaborators of Zhaofei Guo. A scholar is included among the top collaborators of Zhaofei Guo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhaofei Guo. Zhaofei Guo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
He, Penghui, Chun‐Ting He, Rong Guo, et al.. (2025). Tough and waterproof microneedles overcome mucosal immunotolerance by modulating antigen release patterns. Journal of Controlled Release. 382. 113740–113740. 1 indexed citations
2.
He, Chun‐Ting, Penghui He, Yanhua Xu, et al.. (2025). Rectifying the Crosstalk between the Skeletal and Immune Systems Improves Osteoporosis Treatment by Core–Shell Nanocapsules. ACS Nano. 19(5). 5549–5567. 6 indexed citations
3.
Guo, Zhaofei, Chun‐Ting He, Penghui He, et al.. (2025). Antigens and adjuvants co-stabilized Pickering emulsions amplify immune responses of subunit vaccines. Journal of Controlled Release. 379. 177–190. 6 indexed citations
4.
He, Chun‐Ting, Yanhua Xu, Shuting Bai, et al.. (2025). Application of in-silico approaches in subunit vaccines: Overcoming the challenges of antigen and adjuvant development. Journal of Controlled Release. 381. 113629–113629. 2 indexed citations
5.
Guo, Zhaofei, Hu Liao, Yuxi Zhan, et al.. (2025). A Universal Therapeutic Vaccine Leveraging Autologous Pre‐Existing Immunity to Eliminate in Situ Uniformly Engineered Heterogeneous Tumor Cells. Advanced Materials. 37(9). e2412430–e2412430.
6.
He, Penghui, Chun‐Ting He, Shuang Luo, et al.. (2025). Microneedle-delivered adeno-associated virus vaccine amplified anti-viral immunity by improving antigen-presenting cells infection. Journal of Controlled Release. 379. 1045–1057. 3 indexed citations
7.
Guo, Zhaofei, Rui Hu, Yining Zhu, et al.. (2025). Metalloparticle‐Engineered Pickering Emulsion Displaying AAV‐Vectored Vaccine for Enhancing Antigen Expression and Immunogenicity Against Pathogens. Advanced Materials. 37(8). e2412627–e2412627. 5 indexed citations
8.
Guo, Zhaofei, Yanhua Xu, Rui Hu, et al.. (2025). Double-metal ion adjuvant stabilized Pickering emulsion to amplify humoral and cellular immune responses. Nano Research. 18(3). 94907237–94907237.
9.
He, Chun‐Ting, Penghui He, Shuting Bai, et al.. (2024). Zoledronate-loaded aluminum salt nanovaccines amplify cellular immune response by enhancing cross-presentation. Nano Research. 18(1). 94907010–94907010. 1 indexed citations
10.
Li, Chenglong, Zhaofei Guo, Hairui Wang, et al.. (2024). Bacterial and cancerous cell membrane fused liposome coordinates with PD-L1 inhibitor for cancer immunotherapy. Nano Research. 17(9). 8389–8401. 6 indexed citations
11.
Chen, Wenfei, Shuting Bai, Chun‐Ting He, et al.. (2023). Cloaking Mesoporous Polydopamine with Bacterial Membrane Vesicles to Amplify Local and Systemic Antitumor Immunity. ACS Nano. 17(8). 7733–7749. 36 indexed citations
12.
Qiao, Nan, Hairui Wang, Yanhua Xu, et al.. (2023). A Mn Al double adjuvant nanovaccine to induce strong humoral and cellular immune responses. Journal of Controlled Release. 358. 190–203. 28 indexed citations
13.
Guo, Chenqi, Mengying Wu, Zhaofei Guo, et al.. (2023). Hypoxia-Responsive Golgi-Targeted Prodrug Assembled with Anthracycline for Improved Antitumor and Antimetastasis Efficacy. ACS Nano. 17(24). 24972–24987. 17 indexed citations
14.
Chen, Wenfei, Chun‐Ting He, Nan Qiao, et al.. (2022). Dual drugs decorated bacteria irradiate deep hypoxic tumor and arouse strong immune responses. Biomaterials. 286. 121582–121582. 51 indexed citations
15.
Luo, Shuang, Yongshun Zhang, Hairui Wang, et al.. (2022). Single-shot AAV-vectored vaccine against SARS-CoV-2 with fast and long-lasting immunity. Acta Pharmaceutica Sinica B. 13(5). 2219–2233. 20 indexed citations
16.
Guo, Zhaofei, Yining Zhu, Guangsheng Du, et al.. (2022). Rapid development of a subunit nano-vaccine against drug-resistant Pseudomonas aeruginosa with effective cross-protection. Nano Today. 43. 101398–101398. 20 indexed citations
17.
Guo, Chenqi, Ting Zhao, Zhaofei Guo, et al.. (2022). Albumin-based multidrug delivery system enriched in Golgi apparatus against metastatic breast cancer. Nano Research. 16(4). 5640–5652. 5 indexed citations
18.
Qin, Ming, Guangsheng Du, Nan Qiao, et al.. (2021). Whole‐Cell‐Mimicking Carrier‐Free Nanovaccines Amplify Immune Responses Against Cancer and Bacterial Infection. Advanced Functional Materials. 32(10). 21 indexed citations
19.
Zhu, Yining, Jiao Xue, Wenfei Chen, et al.. (2020). Albumin-biomineralized nanoparticles to synergize phototherapy and immunotherapy against melanoma. Journal of Controlled Release. 322. 300–311. 83 indexed citations
20.
Chen, Wenfei, Zhaofei Guo, Yining Zhu, et al.. (2019). Combination of Bacterial‐Photothermal Therapy with an Anti‐PD‐1 Peptide Depot for Enhanced Immunity against Advanced Cancer. Advanced Functional Materials. 30(1). 111 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026